Clinical trials
Recruiting Phase 2 Adenocarcinoma of Lung trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2017 | 1 |
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 11 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Shanghai Pulmonary Hospital, Shanghai, China | 3 |
| Emory University | 1 |
| Hunan Province Tumor Hospital | 1 |
| Lantern Pharma Inc. | 1 |
| Masonic Cancer Center, University of Minnesota | 1 |
| National Taiwan University Hospital | 1 |
| Northwestern University | 1 |
| Samsung Medical Center | 1 |
| Taipei Medical University Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Adenocarcinoma of Lung | 11 |
| Lung Neoplasms | 4 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Carcinoma, Transitional Cell | 1 |
| Colorectal Neoplasms | 1 |
| Neoplasms by Histologic Type | 1 |
| Ovarian Neoplasms | 1 |
| Pancreatic Neoplasms | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.